Short-term prognosis in early relapsing-remitting multiple sclerosis

被引:49
作者
Scott, TF
Schramke, CJ
Novero, J
Chieffe, C
机构
[1] Med Coll Penn & Hahneman Univ, Philadelphia, PA USA
[2] Allegheny Gen Hosp, Dept Neurol, Pittsburgh, PA 15212 USA
关键词
D O I
10.1212/WNL.55.5.689
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To characterize a group of patients with early MS using prognostic factors and to determine whether these prognostic factors impact on short-term prognosis. Methods: Data were collected prospectively on 98 patients newly diagnosed with MS in our MS clinic between 1990 and 1998 (average follow-up, 37 months from the time of onset of clinically definite MS [CDMS]). Six prognostic factors were recorded: age at onset, symptoms at onset, MRI status at onset and at diagnosis of CDMS, interval between the first and second attack, attack frequency in the first 2 years, and completeness of recovery from initial attacks. Completeness of recovery was determined using Expanded Disability Status Scale scores (EDSS). Progression was determined by final EDSS and changes in EDSS between initial presentation and final follow-up. Results: Patients predicted to have low risk of progression of MS based on the prognostic factors represented 17% of our patient population (0 to 1 risk factor for progression). The patients with high risk of progression (4 to 6 risk factors) represented 24% of patients. Patients with a high number of risk factors did significantly worse than those with a small or medium number of risk factors in terms of final ED;SS and progression to higher EDSS. At the time of diagnosis of CDMS, MRI findings suggestive of MS were seen in 84% of patients (suspicious in 13%, negative in 3%). Conclusion: Short-term prognosis was influenced by the presence or absence of a high number of these six risk factors.
引用
收藏
页码:689 / 693
页数:5
相关论文
共 30 条
  • [1] BRAIN MAGNETIC-RESONANCE-IMAGING IN ACUTE OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS STUDY-GROUP
    BECK, RW
    ARRINGTON, J
    MURTAGH, FR
    CLEARY, PA
    KAUFMAN, DI
    [J]. ARCHIVES OF NEUROLOGY, 1993, 50 (08) : 841 - 846
  • [2] COURSE AND PROGNOSIS OF MULTIPLE-SCLEROSIS ASSESSED BY THE COMPUTERIZED DATA-PROCESSING OF 349 PATIENTS
    CONFAVREUX, C
    AIMARD, G
    DEVIC, M
    [J]. BRAIN, 1980, 103 (JUN) : 281 - 300
  • [3] DUQUETTE P, 1995, NEUROLOGY, V45, P1277
  • [4] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    DUQUETTE, P
    GIRARD, M
    DESPAULT, L
    DUBOIS, R
    KNOBLER, RL
    LUBLIN, FD
    KELLEY, L
    FRANCIS, GS
    LAPIERRE, Y
    ANTEL, J
    FREEDMAN, M
    HUM, S
    GREENSTEIN, JI
    MISHRA, B
    MULDOON, J
    WHITAKER, JN
    EVANS, BK
    LAYTON, B
    SIBLEY, WA
    LAGUNA, J
    KRIKAWA, J
    PATY, DW
    OGER, JJ
    KASTRUKOFF, LF
    MOORE, GRW
    HASHIMOTO, SA
    MORRISON, W
    NELSON, J
    GOODIN, DS
    MASSA, SM
    GUTTERIDGE, E
    ARNASON, BGW
    NORONHA, A
    REDER, AT
    MARTIA, R
    EBERS, GC
    RICE, GPA
    LESAUX, J
    JOHNSON, KP
    PANITCH, HS
    BEVER, CT
    CONWAY, K
    WALLENBERG, JC
    BEDELL, L
    VANDENNOORT, S
    WEINSHENKER, B
    WEISS, W
    REINGOLD, S
    PACHNER, A
    TAYLOR, W
    [J]. NEUROLOGY, 1993, 43 (04) : 655 - 661
  • [5] QUANTITATIVE BRAIN MRI LESION LOAD PREDICTS THE COURSE OF CLINICALLY ISOLATED SYNDROMES SUGGESTIVE OF MULTIPLE-SCLEROSIS
    FILIPPI, M
    HORSFIELD, MA
    MORRISSEY, SP
    MACMANUS, DG
    RUDGE, P
    MCDONALD, WI
    MILLER, DH
    [J]. NEUROLOGY, 1994, 44 (04) : 635 - 641
  • [6] CORRELATIONS BETWEEN CHANGES IN DISABILITY AND T-2-WEIGHTED BRAIN MRI ACTIVITY IN MULTIPLE-SCLEROSIS - A FOLLOW-UP-STUDY
    FILIPPI, M
    PATY, DW
    KAPPOS, L
    BARKHOF, F
    COMPSTON, DAS
    THOMPSON, AJ
    ZHAO, GJ
    WILES, CM
    MCDONALD, WI
    MILLER, DH
    [J]. NEUROLOGY, 1995, 45 (02) : 255 - 260
  • [7] LONG-TERM FOLLOW-UP OF ACUTE PARTIAL TRANSVERSE MYELOPATHY
    FORD, B
    TAMPIERI, D
    FRANCIS, G
    [J]. NEUROLOGY, 1992, 42 (01) : 250 - 252
  • [8] Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis
    Jacobs, LD
    Cookfair, DL
    Rudick, RA
    Herndon, RM
    Richert, JR
    Salazar, AM
    Fischer, JS
    Goodkin, DE
    Granger, CV
    Simon, JH
    Alam, JJ
    Bartoszak, DM
    Bourdette, DN
    Braiman, J
    Brownscheidle, CM
    Coats, ME
    Cohan, SL
    Dougherty, DS
    Kinkel, RP
    Mass, MK
    Munschauer, FE
    Priore, RL
    Pullicino, PM
    Scherokman, BJ
    WeinstockGuttman, B
    Whitman, RH
    Baird, WC
    Fillmore, M
    Bona, LM
    ColonRuiz, ME
    Nadine, BS
    Donovan, A
    Bennett, S
    Kieffer, YM
    Umhauer, MA
    Miller, CE
    Kilic, AK
    Sargent, EL
    Schachter, M
    Shucard, DW
    Weider, V
    Catalano, BA
    Cervi, JM
    Czekay, C
    Farrell, JL
    Filippini, JS
    Matyas, RC
    Michienzi, KE
    Ito, M
    OMalley, JA
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (03) : 285 - 294
  • [9] COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    JOHNSON, KP
    BROOKS, BR
    COHEN, JA
    FORD, CC
    GOLDSTEIN, J
    LISAK, RP
    MYERS, LW
    PANITCH, HS
    ROSE, JW
    SCHIFFER, RB
    VOLLMER, T
    WEINER, LP
    WOLINSKY, JS
    BIRD, SJ
    CONSTANTINESCU, C
    KOLSON, DL
    GONZALEZSCARANO, F
    BRENNAN, D
    PFOHL, D
    MANDLER, RN
    ROSENBERG, GA
    JEFFREY, C
    BARGER, GR
    GANDHI, B
    MOORE, PM
    ROGERS, LR
    LISAK, D
    SMITH, L
    ELLISON, GW
    BAUMHEFNER, RW
    CRAIG, SL
    JALBUT, SS
    KATZ, E
    CONWAY, KL
    BURNS, JB
    SHIBA, C
    GIANG, DW
    PETRIE, MD
    GUARNACCIA, JB
    ANDERSON, S
    MCKEON, A
    MCCARTHY, M
    THOMAS, AB
    VRIESENDORP, FJ
    AUSTIN, SG
    LINDSEY, JW
    DIMACHKIE, M
    CERRETA, E
    KACHUCK, N
    MCCARTHY, KA
    [J]. NEUROLOGY, 1995, 45 (07) : 1268 - 1276
  • [10] Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis
    Kappos, L
    Moeri, D
    Radue, EW
    Schoetzau, A
    Schweikert, K
    Barkhof, F
    Miller, D
    Guttmann, CRG
    Weiner, HL
    Gasperini, C
    Filippi, M
    [J]. LANCET, 1999, 353 (9157) : 964 - 969